Page 174 - Binder2

• Synthetic biology and plant molecular farming
have reached a point of precision where proteins
can now be engineered into specific plant organelles
(e.g., chloroplasts) for higher yield and enhanced
immune compatibility. We're no longer speculating
on feasibility—we’re optimizing it.

A Convergence of Disciplines

Edible biologics represent more than a new delivery
method—they’re the convergence of three frontier fields:

• Plant-based biotechnology – leveraging
photosynthetic organisms to produce complex
therapeutics with minimal infrastructure
• Clinical immunology – tapping into mucosal and
oral tolerance pathways to enhance immune
compatibility
• Therapeutic design – engineering proteins not just
to act on targets, but to persist within complex
biological systems

Together, these disciplines are shaping a new class of
therapies that are not just cheaper or easier to
administer, but fundamentally more aligned with how the
body learns, tolerates, and heals.

And that makes this moment not just an inflection point—
It makes it a turning point.

The important part now is how.

172